TEZEPELUMAB EFFICACY ACCORDING TO BRONCHODILATOR REVERSIBILITY IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN NAVIGATOR

被引：0
|
作者：
Menzies-Gow, A.
Bourdin, A.
Korn, S.
Cook, B.
Ambrose, C.
Ponnarambil, S.
Hunter, G.
Molfino, N.
Colice, G.
Llanos-Ackert, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P080
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY PRIOR OMALIZUMAB USE: A POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY
    Menzies-Gow, A.
    Colice, G.
    Ambrose, C. S.
    Martin, N.
    Llanos, J. P.
    Hellqvist, A.
    Cook, B.
    Caminati, M.
    THORAX, 2023, 78 (SUPPL_4) : A273 - A274
  • [32] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES
    Corren, Jonathan
    Wechsler, Michael E.
    Chupp, Geoffrey L.
    Ambrose, Christopher
    Roseti, Stephanie L.
    Hellqvist, Asa
    Ackert, Jean-Pierre Llanos
    Martin, Neil
    Colice, Gene L.
    CHEST, 2022, 162 (04) : 21A - 22A
  • [33] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Prior Omalizumab Use: A Post Hoc Analysis of the Phase 3 Navigator Study
    Menzies-Gow, A.
    Colice, G.
    Ambrose, C. S.
    Llanos, J.
    Hellqvist, A.
    Cook, B.
    Caminati, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY
    Kraft, Monica
    Colice, Gene L.
    Ambrose, Christopher
    Cook, William
    Hunter, Gillian
    Molfino, Eleonora A.
    Martin, Neil
    Roseti, Stephanie L.
    CHEST, 2022, 162 (04) : 11A - 12A
  • [35] Clinical Responses to Tezepelumab in Patients With Severe, Uncontrolled Asthma, and a History of Nasal Polyps From the NAVIGATOR Study
    Lugogo, N. L.
    Peters, A. T.
    Chupp, G. L.
    Wechsler, M. E.
    Caveney, S.
    Martin, N.
    Parikh, B.
    Ambrose, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [36] Effect of tezepelumab on exacerbation-related intravenous corticosteroid use in patients with severe, uncontrolled asthma in NAVIGATOR
    Bourdin, A.
    Martin, N.
    Ambrose, C.
    Ponnarambil, S.
    Hunter, G.
    Molfino, N.
    Cook, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [37] Clinical Responses to Treatment with Tezepelumab Among Patients with Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
    Lugogo, N. L.
    Ambrose, C. S.
    Colice, G.
    Kmita, K.
    Cook, B.
    Ponnarambil, S.
    Ackert, J. Llanos
    Menzies-Gow, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Menzies-Gow, Andrew
    Corren, Jonathan
    Bourdin, Arnaud
    Chupp, Geoffrey
    Israel, Elliot
    Griffiths, Janet
    Hellqvist, Asa
    Bowen, Karin
    Kaur, Primal
    Almqvist, Gun
    Ponnarambil, Sandhia
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB249 - AB249
  • [39] Tezepelumab in the Treatment of Uncontrolled Severe Asthma
    Feist, Jacqueline
    Lipari, Melissa
    Kale-Pradhan, Pramodini
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (01) : 62 - 70
  • [40] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR
    Wechsler, Michael E.
    Chupp, Geoffrey L.
    Israel, Elliot
    Castro, Mario
    Bober, Magdalena
    Lindsley, Andrew
    Spahn, Joe D.
    Ambrose, Christopher S.
    CHEST, 2024, 166 (04) : 4664A - 4680A
12345